The biggest catalyst for ARS Pharmaceuticals SPRY nobody is watching Momentum Fading 20260508 IRD Opus Genetics trades modestly higher post Q4 2025 earnings despite wider than expected per share losses Is Mainz QUCY stock slowing down Mainz posts 257 percent EPS beat with smaller than expected loss NMP acquisition pipeline strengthens as strategic shift gains momentum investors await clearer financial picture